Cargando…
Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas
Recurrence is frequent in pediatric ependymoma (EPN). Our longitudinal integrated analysis of 30 patient-matched repeated relapses (3.67 ± 1.76 times) over 13 years (5.8 ± 3.8) reveals stable molecular subtypes (RELA and PFA) and convergent DNA methylation reprogramming during serial relapses accomp...
Autores principales: | Zhao, Sibo, Li, Jia, Zhang, Huiyuan, Qi, Lin, Du, Yuchen, Kogiso, Mari, Braun, Frank K., Xiao, Sophie, Huang, Yulun, Li, Jianfang, Teo, Wan-Yee, Lindsay, Holly, Baxter, Patricia, Su, Jack M. F., Adesina, Adekunle, Laczik, Miklós, Genevini, Paola, Veillard, Anne-Clemence, Schvartzman, Sol, Berguet, Geoffrey, Ding, Shi-Rong, Du, Liping, Stephan, Clifford, Yang, Jianhua, Davies, Peter J. A., Lu, Xinyan, Chintagumpala, Murali, Parsons, Donald William, Perlaky, Laszlo, Xia, Yun-Fei, Man, Tsz-Kwong, Huang, Yun, Sun, Deqiang, Li, Xiao-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637194/ https://www.ncbi.nlm.nih.gov/pubmed/36335125 http://dx.doi.org/10.1038/s41467-022-34514-z |
Ejemplares similares
-
EPEN-46. DNA METHYLATION LANDSCAPE OF RECURRENT PEDIATRIC EPENDYMOMA IDENTIFIES KEY DRIVER EVENTS
por: Zhao, Sibo, et al.
Publicado: (2020) -
Publisher Correction: Epigenetic alterations of repeated relapses in patient-matched childhood ependymomas
por: Zhao, Sibo, et al.
Publicado: (2022) -
EPEN-02. Adaptive Convergence of Methylomes Reveals Epigenetic Drivers and Boosters of Repeated Relapses in Patient-matched Childhood Ependymomas and Identifies Targets for Anti-Recurrence Therapies
por: Zhao, Sibo, et al.
Publicado: (2022) -
Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion
por: Huang, Yulun, et al.
Publicado: (2021) -
Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma
por: Kogiso, Mari, et al.
Publicado: (2022)